The Recombinant Human Secretory Leukocyte Protease Inhibitor (SLPI) protects cardiac fibroblasts injury against an in vitro ischemia/reperfusion injury
Nitchawat Paiyabhroma, Nitirut Nernpermpisooth, Sarawut Kumphune
DOI: 10.7324/JAPS.2018.8620Pages: 156-162
